AEBP1 inhibition reduces cell growth and PI3K/AKT pathway while less regulates cell mobility in hepatocellular carcinoma
AEBP1 exhibits the potency to be a target for HCC treatment, reflected by its regulation on HCC proliferation, apoptosis and PI3K/AKT pathway, but its effect on HCC invasion and migration seems limited.
Authors
- Liyou Liu
- Qingshan Cai
- Dong Liu (ORCID: https://orcid.org/0000-0001-7603-8927)
- Shudong Li (ORCID: https://orcid.org/0000-0001-6347-9539)
- Dongyang Wu (ORCID: https://orcid.org/0000-0002-3787-8365)
- Jianxing Zheng (ORCID: https://orcid.org/0000-0003-1412-6336)
Institutions
- Tangshan People's Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1186/s12957-025-03750-0
- Citations
- 2
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 2.94